Xiao‐Feng Zhu
- Cancer Research top 1%
- Cancer-related molecular mechanisms research 13
- MicroRNA in disease regulation 11
- Aging top 2%
- Molecular Biology top 2%
- RNA modifications and cancer 15
- Cancer-related gene regulation 10
- PI3K/AKT/mTOR signaling in cancer 9
- Cell death mechanisms and regulation 8
- Oncology top 2%
- Epidemiology top 2%
- Autophagy in Disease and Therapy 12
-
- Marine Sponges and Natural Products 9
Xiao‐Feng Zhu
142 papers receiving 5.1k citations
Hit Papers
Peers
Comparison fields: 5 of 138
- Cancer Research 1.2k
- Aging 113
- Molecular Biology 3.0k
- Oncology 1.0k
- Epidemiology 1.1k
Countries citing papers authored by Xiao‐Feng Zhu
This map shows the geographic impact of Xiao‐Feng Zhu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiao‐Feng Zhu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiao‐Feng Zhu more than expected).
Fields of papers citing papers by Xiao‐Feng Zhu
This network shows the impact of papers produced by Xiao‐Feng Zhu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiao‐Feng Zhu. The network helps show where Xiao‐Feng Zhu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Xiao‐Feng Zhu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 11 | |
| 2 | 2024 | 1 | |
| 3 | 2024 | 2 | |
| 4 | 2024 | 6 | |
| 5 | 2024 | 0 | |
| 6 | 2023 | 10 | |
| 7 | 2022 | 6 | |
| 8 | 2022 | 26 | |
| 9 | 2019 | 80 | |
| 10 | LncRNA LINRIS stabilizes IGF2BP2 and promotes the aerobic glycolysis in colorectal cancerbreakdown → | 2019 | 374 |
| 11 | 2019 | 3 | |
| 12 | 2017 | 26 | |
| 13 | 2013 | 34 | |
| 14 | 2011 | 12 | |
| 15 | 2011 | 54 | |
| 16 | 2011 | 28 | |
| 17 | 2010 | 43 | |
| 18 | 2007 | 99 | |
| 19 | 2005 | 14 | |
| 20 | 2002 | 2 |
About Xiao‐Feng Zhu
Xiao‐Feng Zhu is a scholar working on Cancer Research, Transplantation and Biotechnology, having authored 145 papers that have together received 5.1k indexed citations. Recurring topics across this work include RNA modifications and cancer (15 papers), Cancer-related molecular mechanisms research (13 papers), Autophagy in Disease and Therapy (12 papers), MicroRNA in disease regulation (11 papers), Cancer-related gene regulation (10 papers), PI3K/AKT/mTOR signaling in cancer (9 papers), Marine Sponges and Natural Products (9 papers) and Cell death mechanisms and regulation (8 papers). The work is most often cited by research in Cancer Research (1.2k citations), Aging (113 citations) and Molecular Biology (3.0k citations). Xiao‐Feng Zhu has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Rong Deng, Gong-Kan Feng, Yi-Xin Zeng, Dandan Li, Daniel Cohen, François Schächter, Rita B. Effros, Homayoun Vaziri, Lixin Wei and Irene A. Uchida. Their work appears in journals such as Nature, Proceedings of the National Academy of Sciences and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.